Steven Cohen Exact Sciences Corp Call Options Transaction History

Point72 Asset Management, L.P.

  • $36 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
BUY
$56.27 - $73.77 $7.32 Million - $9.59 Million
130,000 Added 325.0%
170,000 $11.7 Million
Q4 2023

Feb 14, 2024
BUY
$59.06 - $75.72 $2.36 Million - $3.03 Million
40,000 New
40,000 $2.96 Million
Q3 2022

Nov 14, 2022
BUY
$31.97 - $49.37 $799,250 - $1.23 Million
25,000 New
25,000 $812,000

Others Institutions Holding EXAS

# of Institutions
610
Shares Held
166M
Call Options Held
1.93M
Put Options Held
1.23M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email